CIM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Chimera Investment Corp (CIM) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock shows some technical bullishness, the lack of significant positive catalysts, poor financial performance, and a recent downgrade by analysts suggest that it is better to hold off on investing in this stock right now.
The technical indicators show mixed signals. The MACD is positive but contracting, RSI is neutral at 70.249, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 13.832), which could limit short-term upside potential.
The company is diversifying its revenue streams and business model, which could be beneficial in the long term. Technical indicators show bullish moving averages.
Poor financial performance in Q4 2025, with net income and EPS dropping significantly. No recent news or significant hedge fund/insider activity. Congress trading data is unavailable.
In Q4 2025, revenue increased by 10.48% YoY to $222.67M. However, net income dropped by -103.86% YoY to $6.5M, and EPS fell by -103.40% YoY to $0.07. Gross margin also declined by -16.41% YoY to 28.07, indicating deteriorating profitability.
RBC Capital downgraded Chimera to Sector Perform from Outperform with a price target of $13, citing much lower expected ROE in 2026 compared to peers. Analysts appreciate the company's diversification efforts but see better value elsewhere in the sector.
